Assessment of Retinal Vascular Changes With and Without ILM Peeling in Diabetic Vitrectomy Using Optical Coherence Tomography Angiography.

Status: Completed
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Tractional retinal detachment (TRD) that involves the macula and non-clearing vitreous hemorrhage are the main causes of permanent vision loss in patients with diabetic retinopathy and requires prompt surgical intervention. Macular peeling is a surgical technique used in many retinal diseases including diabetic retinal detachment. Our purpose is to determine whether retinal microcirculatory changes occur after anatomically successful diabetic vitrectomy, and whether changes in blood flow vary if ILM peeling was done and whether changes in macular perfusion affect the final visual outcome. The aim of this study is to non-invasively evaluate, with optical coherence tomography angiography (OCT-A), the anatomical changes of deep and superficial vascular density in the macula with and without macular peeling in diabetic vitrectomy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age above 18 years old of both sexes.

• Patients having diabetic tractional retinal detachement threatening the macula (traction over posterior pole with attached fovea).

• Combined tractional-rhegmatogenous retinal detachement with attached macula.

• Diabetic persistent fibrovascular proliferation not responding to panretinal photocoagulation.

• Non clearing diabetic vitreous hemorrhage, subhyaloid hemorrhage.

Locations
Other Locations
Egypt
KasrAlaini hospital
Cairo
Time Frame
Start Date: 2022-04-01
Completion Date: 2024-01-05
Participants
Target number of participants: 36
Treatments
Active_comparator: pars plana vitrectomy with ILM peeling
Diabetic patients who fulfill the inclusion critera and will undergo pars plana vitrectomy and ILM peeling
Active_comparator: pars plana vitrectomy without ILM peeling
Diabetic patients who fulfill the inclusion critera and will undergo pars plana vitrectomy without ILM peeling
Sponsors
Leads: Kasr El Aini Hospital

This content was sourced from clinicaltrials.gov